Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Jan;41(1):66–71. doi: 10.1128/aac.41.1.66

Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues.

N E Allen 1, D L LeTourneau 1, J N Hobbs Jr 1
PMCID: PMC163661  PMID: 8980756

Abstract

LY191145 is an N-alkylated glycopeptide antibiotic (the p-chlorobenzyl derivative of LY264826) with activity against vancomycin-susceptible and -resistant bacteria. Similar to vancomycin, LY191145 inhibited polymerization of peptidoglycan when muramyl pentapeptide served as a substrate but not when muramyl tetrapeptide was used, signifying a substrate-dependent mechanism of inhibition. Examination of ligand binding affinities for LY191145 and the effects of this agent on R39 D,D-carboxypeptidase action showed that, similar to vancomycin, LY191145 had an 800-fold greater affinity for N,N'-diacetyl-L-Lys-D-Ala-D-Ala than for N,N'-diacetyl-L-Lys-D-Ala-D-Lac. The antibacterial activity of LY191145 was antagonized by N,N'-diacetyl-L-Lys-D-Ala-D-Ala, but the molar excess required for complete suppression exceeded that needed to suppress inhibition by vancomycin. LY191145 is strongly dimerized and the p-chlorobenzyl side chain facilitates interactions with bacterial membranes. These findings are consistent with a mechanism of inhibition where interactions between antibiotic and D-Ala-D-Ala or D-Ala-D-Lac residues depend on intramolecular effects occurring at the subcellular target site.

Full Text

The Full Text of this article is available as a PDF (256.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen N. E., Hobbs J. N., Jr, Nicas T. I. Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic. Antimicrob Agents Chemother. 1996 Oct;40(10):2356–2362. doi: 10.1128/aac.40.10.2356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen N. E., Hobbs J. N., Jr, Richardson J. M., Riggin R. M. Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium. FEMS Microbiol Lett. 1992 Nov 1;77(1-3):109–115. doi: 10.1016/0378-1097(92)90140-j. [DOI] [PubMed] [Google Scholar]
  3. Barna J. C., Williams D. H. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu Rev Microbiol. 1984;38:339–357. doi: 10.1146/annurev.mi.38.100184.002011. [DOI] [PubMed] [Google Scholar]
  4. Beauregard D. A., Williams D. H., Gwynn M. N., Knowles D. J. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob Agents Chemother. 1995 Mar;39(3):781–785. doi: 10.1128/AAC.39.3.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bugg T. D., Wright G. D., Dutka-Malen S., Arthur M., Courvalin P., Walsh C. T. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry. 1991 Oct 29;30(43):10408–10415. doi: 10.1021/bi00107a007. [DOI] [PubMed] [Google Scholar]
  6. Chatterjee A. N., Perkins H. R. Compounds formed between nucleotides related to the biosynthesis of bacterial cell wall and vancomycin. Biochem Biophys Res Commun. 1966 Aug 12;24(3):489–494. doi: 10.1016/0006-291x(66)90188-4. [DOI] [PubMed] [Google Scholar]
  7. Gomez F. A., Avila L. Z., Chu Y. H., Whitesides G. M. Determination of binding constants of ligands to proteins by affinity capillary electrophoresis: compensation for electroosmotic flow. Anal Chem. 1994 Jun 1;66(11):1785–1791. doi: 10.1021/ac00083a003. [DOI] [PubMed] [Google Scholar]
  8. Groves P., Searle M. S., Mackay J. P., Williams D. H. The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics. Structure. 1994 Aug 15;2(8):747–754. doi: 10.1016/s0969-2126(94)00075-1. [DOI] [PubMed] [Google Scholar]
  9. Hammes W. P., Neuhaus F. C. Biosynthesis of peptidoglycan in Gaffkya homari: role of the peptide subunit of uridine diphosphate-N-acetylmuramyl-pentapeptide. J Bacteriol. 1974 Oct;120(1):210–218. doi: 10.1128/jb.120.1.210-218.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Handwerger S., Pucci M. J., Volk K. J., Liu J., Lee M. S. The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate. J Bacteriol. 1992 Sep;174(18):5982–5984. doi: 10.1128/jb.174.18.5982-5984.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Izaki K., Strominger J. L. Biosynthesis of the peptidoglycan of bacterial cell walls. XIV. Purification and properties of two D-alanine carboxypeptidases from Escherichia coli. J Biol Chem. 1968 Jun 10;243(11):3193–3201. [PubMed] [Google Scholar]
  12. Johnson K., Duez C., Frère J. M., Ghuysen J. M. Beta-lactamases (Actinomycetes species). Methods Enzymol. 1975;43:687–698. doi: 10.1016/0076-6879(75)43134-2. [DOI] [PubMed] [Google Scholar]
  13. Konings W. N., Bisschop A., Veenhuis M., Vermeulen C. A. New procedure for the isolation of membrane vesicles of Bacillus subtilis and an electron microscopy study of their ultrastructure. J Bacteriol. 1973 Dec;116(3):1456–1465. doi: 10.1128/jb.116.3.1456-1465.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Leyh-Bouille M., Ghuysen J. M., Nieto M., Perkins H. R., Schleifer K. H., Kandler O. On the Streptomyces albus G DD carboxypeptidase mechanism of action of penicillin, vancomycin, and ristocetin. Biochemistry. 1970 Jul 21;9(15):2971–2975. doi: 10.1021/bi00817a006. [DOI] [PubMed] [Google Scholar]
  15. Linsdell H., Toiron C., Bruix M., Rivas G., Menéndez M. Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides. J Antibiot (Tokyo) 1996 Feb;49(2):181–193. doi: 10.7164/antibiotics.49.181. [DOI] [PubMed] [Google Scholar]
  16. Messer J., Reynolds P. E. Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci. FEMS Microbiol Lett. 1992 Jul 1;73(1-2):195–200. doi: 10.1016/0378-1097(92)90608-q. [DOI] [PubMed] [Google Scholar]
  17. Nagarajan R. Structure-activity relationships of vancomycin-type glycopeptide antibiotics. J Antibiot (Tokyo) 1993 Aug;46(8):1181–1195. doi: 10.7164/antibiotics.46.1181. [DOI] [PubMed] [Google Scholar]
  18. Nguyen-Distèche M., Leyh-Bouille M., Pirlot S., Frère J. M., Ghuysen J. M. Streptomyces K15 DD-peptidase-catalysed reactions with ester and amide carbonyl donors. Biochem J. 1986 Apr 1;235(1):167–176. doi: 10.1042/bj2350167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nicas T. I., Mullen D. L., Flokowitsch J. E., Preston D. A., Snyder N. J., Stratford R. E., Cooper R. D. Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria. Antimicrob Agents Chemother. 1995 Nov;39(11):2585–2587. doi: 10.1128/aac.39.11.2585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nicas T. I., Wu C. Y., Hobbs J. N., Jr, Preston D. A., Allen N. E. Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother. 1989 Jul;33(7):1121–1124. doi: 10.1128/aac.33.7.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nieto M., Perkins H. R. Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin. Biochem J. 1971 Aug;123(5):789–803. doi: 10.1042/bj1230789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nieto M., Perkins H. R. Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-L-lysyl-D-alanyl-D-alanine. Biochem J. 1971 Aug;123(5):773–787. doi: 10.1042/bj1230773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nieto M., Perkins H. R., Reynolds P. E. Reversal by a specific peptide (diacetyl-alpha gamma-L-diaminobutyryl-D-alanyl-D-alanine) of vancomycin inhibition in intact bacteria and cell-free preparations. Biochem J. 1972 Jan;126(1):139–149. doi: 10.1042/bj1260139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Perkins H. R., Nieto M. The chemical basis for the action of the vancomycin group of antibiotics. Ann N Y Acad Sci. 1974 May 10;235(0):348–363. doi: 10.1111/j.1749-6632.1974.tb43276.x. [DOI] [PubMed] [Google Scholar]
  25. Popieniek P. H., Pratt R. F. A fluorescent ligand for binding studies with glycopeptide antibiotics of the vancomycin class. Anal Biochem. 1987 Aug 15;165(1):108–113. doi: 10.1016/0003-2697(87)90207-7. [DOI] [PubMed] [Google Scholar]
  26. Reynolds P. E. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis. 1989 Nov;8(11):943–950. doi: 10.1007/BF01967563. [DOI] [PubMed] [Google Scholar]
  27. Rolston K. V., Nguyen H., Messer M. In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer. Antimicrob Agents Chemother. 1990 Nov;34(11):2137–2141. doi: 10.1128/aac.34.11.2137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Roth G. S., Shockman G. D., Daneo-Moore L. Balanced macromolecular biosynthesis in "protoplasts" of Streptococcus faecalis. J Bacteriol. 1971 Mar;105(3):710–717. doi: 10.1128/jb.105.3.710-717.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tanaka H., Oiwa R., Matsukura S., Omura S. Amphomycin inhibits phospho-N-acetylmuramyl-pentapeptide translocase in peptidoglycan synthesis of Bacillus. Biochem Biophys Res Commun. 1979 Feb 14;86(3):902–908. doi: 10.1016/0006-291x(79)91797-2. [DOI] [PubMed] [Google Scholar]
  30. Uttley A. H., Collins C. H., Naidoo J., George R. C. Vancomycin-resistant enterococci. Lancet. 1988 Jan 2;1(8575-6):57–58. doi: 10.1016/s0140-6736(88)91037-9. [DOI] [PubMed] [Google Scholar]
  31. Westwell M. S., Gerhard U., Williams D. H. Two conformers of the glycopeptide antibiotic teicoplanin with distinct ligand binding sites. J Antibiot (Tokyo) 1995 Nov;48(11):1292–1298. doi: 10.7164/antibiotics.48.1292. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES